118 related articles for article (PubMed ID: 16938574)
21. MAD2DeltaC induces aneuploidy and promotes anchorage-independent growth in human prostate epithelial cells.
To-Ho KW; Cheung HW; Ling MT; Wong YC; Wang X
Oncogene; 2008 Jan; 27(3):347-57. PubMed ID: 17621272
[TBL] [Abstract][Full Text] [Related]
22. [Research prostate carcinoma in the dog at the University Clinic for Companion Animals in Utrecht, the Netherlands].
L'Eplattenier H
Tijdschr Diergeneeskd; 2003 Feb; 128(4):120-1. PubMed ID: 12625160
[No Abstract] [Full Text] [Related]
23. Immunostaining of the androgen receptor and sequence analysis of its DNA-binding domain in canine prostate cancer.
Lai CL; van den Ham R; Mol J; Teske E
Vet J; 2009 Sep; 181(3):256-60. PubMed ID: 18583166
[TBL] [Abstract][Full Text] [Related]
24. Clinical and pathologic aspects of spontaneous canine prostate carcinoma: a retrospective analysis of 76 cases.
Cornell KK; Bostwick DG; Cooley DM; Hall G; Harvey HJ; Hendrick MJ; Pauli BU; Render JA; Stoica G; Sweet DC; Waters DJ
Prostate; 2000 Oct; 45(2):173-83. PubMed ID: 11027417
[TBL] [Abstract][Full Text] [Related]
25. Canine prostatic carcinoma.
Axiak SM; Bigio A
Compend Contin Educ Vet; 2012 Oct; 34(10):E1-5. PubMed ID: 23532757
[TBL] [Abstract][Full Text] [Related]
26. Genetic profile identification in clinically localized prostate carcinoma.
Gallucci M; Merola R; Leonardo C; De Carli P; Farsetti A; Sentinelli S; Sperduti I; Mottolese M; Carlini P; Vico E; Simone G; Cianciulli A
Urol Oncol; 2009; 27(5):502-8. PubMed ID: 18534873
[TBL] [Abstract][Full Text] [Related]
27. Canine prostatic disease: a review of anatomy, pathology, diagnosis, and treatment.
Smith J
Theriogenology; 2008 Aug; 70(3):375-83. PubMed ID: 18514299
[TBL] [Abstract][Full Text] [Related]
28. Integrative analysis of genomic aberrations associated with prostate cancer progression.
Kim JH; Dhanasekaran SM; Mehra R; Tomlins SA; Gu W; Yu J; Kumar-Sinha C; Cao X; Dash A; Wang L; Ghosh D; Shedden K; Montie JE; Rubin MA; Pienta KJ; Shah RB; Chinnaiyan AM
Cancer Res; 2007 Sep; 67(17):8229-39. PubMed ID: 17804737
[TBL] [Abstract][Full Text] [Related]
29. Histopathological Terminology Standards for the Reporting of Prostatic Epithelial Lesions in Dogs.
Palmieri C; Foster RA; Grieco V; Fonseca-Alves CE; Wood GA; Culp WTN; Murua Escobar H; De Marzo AM; Laufer-Amorim R
J Comp Pathol; 2019 Aug; 171():30-37. PubMed ID: 31540623
[TBL] [Abstract][Full Text] [Related]
30. Ultrastructural changes in prostate cells during hormone-induced canine prostatic hyperplasia.
Gallardo-Arrieta F; Mogas T; Magán L; García MA; García F; Abal M; Morote J; Serrano S; Reventós J; Lioreta J
Ultrastruct Pathol; 2006; 30(6):435-42. PubMed ID: 17182436
[TBL] [Abstract][Full Text] [Related]
31. Significance of chemoprevention for prostate cancer development: experimental in vivo approaches to chemoprevention.
Shirai T
Pathol Int; 2008 Jan; 58(1):1-16. PubMed ID: 18067635
[TBL] [Abstract][Full Text] [Related]
32. Deletion at chromosome arms 6q16-22 and 10q22.3-23.1 associated with initiation of prostate cancer.
Lu T; Hano H
Prostate Cancer Prostatic Dis; 2008; 11(4):357-61. PubMed ID: 18227855
[TBL] [Abstract][Full Text] [Related]
33. Prostatic adenocarcinoma in a castrated dog.
Evans JE; Zontine W; Grain E
J Am Vet Med Assoc; 1985 Jan; 186(1):78-80. PubMed ID: 3965432
[TBL] [Abstract][Full Text] [Related]
34. Bub1 up-regulation and hyperphosphorylation promote malignant transformation in SV40 tag-induced transgenic mouse models.
Guo C; Wu G; Chin JL; Bauman G; Moussa M; Wang F; Greenberg NM; Taylor SS; Xuan JW
Mol Cancer Res; 2006 Dec; 4(12):957-69. PubMed ID: 17189386
[TBL] [Abstract][Full Text] [Related]
35. Genetic changes in pT2 and pT3 prostate cancer detected by comparative genomic hybridization.
Fukasawa S; Kino M; Kobayashi M; Suzuki H; Komiya A; Imamoto T; Hirokawa Y; Shiraishi T; Takiguchi M; Ishida H; Shindo T; Seki N; Ichikawa T
Prostate Cancer Prostatic Dis; 2008; 11(3):303-10. PubMed ID: 17923855
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic exercise: epithelioid hemangiosarcoma mimicking metastatic prostatic neoplasia in a dog.
Shor S; Helfand SC; Gorman E; Löhr CV
Vet Pathol; 2009 May; 46(3):548-52. PubMed ID: 19176508
[TBL] [Abstract][Full Text] [Related]
37. Expression of androgen, oestrogen alpha and beta, and progesterone receptors in the canine prostate: differences between normal, inflamed, hyperplastic and neoplastic glands.
Gallardo F; Mogas T; Baró T; Rabanal R; Morote J; Abal M; Reventós J; Lloreta J
J Comp Pathol; 2007 Jan; 136(1):1-8. PubMed ID: 17078963
[TBL] [Abstract][Full Text] [Related]
38. Lymphoepithelioma-like carcinoma of the prostate.
Lopez-Beltran A; Cheng L; Prieto R; Blanca A; Montironi R
Hum Pathol; 2009 Jul; 40(7):982-7. PubMed ID: 19269013
[TBL] [Abstract][Full Text] [Related]
39. Prostate cancer prevention.
Nelson WG
Curr Opin Urol; 2007 May; 17(3):157-67. PubMed ID: 17414513
[TBL] [Abstract][Full Text] [Related]
40. The discovery of common recurrent transmembrane protease serine 2 (TMPRSS2)-erythroblastosis virus E26 transforming sequence (ETS) gene fusions in prostate cancer: significance and clinical implications.
Shah RB; Chinnaiyan AM
Adv Anat Pathol; 2009 May; 16(3):145-53. PubMed ID: 19395877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
